We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Lee’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A96664 · Current
Licensed to practise in California · since 2006 · expires 2027-12-31 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
Procedure volume Medicare published
Melanoma (skin cancer) excision
1-10
—None
Medicaid work
$2,982 in 2024
Medicaid paid $2,982 for 129 billed services this clinician did in 2024, up to 28 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
Largest Medicaid services in 2024
Short return visit
84
$2,960
OFF/OP EST MAY X REQ PHY/QHP
45
$22
Medicaid work by year
2024
129
2
28
$2,982
2023
16
1
15
$155
See the largest Medicaid services in earlier years
2023
Largest Medicaid services in 2023
Short return visit
16
$155
Drugs they prescribed that Part D paid
$822
Pharmacies billed $822 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 32% of their Part D prescriptions (34 of 106) in 2024. Above the middle of the specialty; the typical orthopedic surgery clinician is at 31%.
105 generic and fewer than 11 brand-name prescriptions · $822 in drug cost · 23 antibiotic prescriptions to 21 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Largest Part D drug costs
Meloxicam
33
$257
$6
Cephalexin
19
$184
$9
Tramadol
14
$101
$6
Year by year
Part D prescribing by year
2024
106
63
32% (34)
—None
$822
2023
94
43
22% (21)
0%
$940
2022
138
69
19% (26)
0%
$1,397
2021
152
76
26% (40)
—None
$1,559
2020
105
73
28% (29)
—None
$1,680
2019
64
48
42% (27)
—None
$1,327
2018
57
43
77% (44)
—None
$843
2017
49
36
55% (27)
—None
$1,177
2016
47
34
64% (30)
0%
$697
2015
42
31
60% (25)
—None
$1,296
2014
62
41
47% (29)
—None
$1,912
2013
64
47
48% (31)
—None
$817
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
Part D drugs prescribed in 2023
Meloxicam
34
$234
$7
Cephalexin
17
$205
$12
2022: 4 drugs
Part D drugs prescribed in 2022
Diclofenac
16
$451
$28
Meloxicam
63
$420
$7
Cephalexin
21
$176
$8
Oxycodone
14
$88
$6
2021: 5 drugs
Part D drugs prescribed in 2021
Meloxicam
67
$443
$7
Diclofenac
17
$427
$25
Oxycodone
24
$149
$6
Cephalexin
13
$133
$10
Tramadol
12
$74
$6
2020: 4 drugs
Part D drugs prescribed in 2020
Diclofenac
17
$482
$28
Meloxicam
37
$229
$6
Cephalexin
11
$116
$11
Hydrocodone-Acetaminophen
13
$97
$7
2019: 1 drug
Part D drugs prescribed in 2019
Hydrocodone-Acetaminophen
23
$151
$7
2018: 1 drug
Part D drugs prescribed in 2018
Hydrocodone-Acetaminophen
27
$199
$7
2017: 2 drugs
Part D drugs prescribed in 2017
Hydrocodone-Acetaminophen
15
$177
$12
Cephalexin
11
$82
$7
2016: 1 drug
Part D drugs prescribed in 2016
Hydrocodone-Acetaminophen
22
$404
$18
2015: 1 drug
Part D drugs prescribed in 2015
Hydrocodone-Acetaminophen
25
$490
$20
2014: 1 drug
Part D drugs prescribed in 2014
Hydrocodone-Acetaminophen
18
$465
$26
2013: 2 drugs
Part D drugs prescribed in 2013
Hydrocodone-Acetaminophen
19
$340
$18
Meloxicam
11
$81
$7
Money from drug and device companies
$202 in 2025
Industry payments by year
2025
1
1
—None
$202
2024
2
2
—None
$387
2023
1
1
—None
$214
2022
2
2
—None
$297
2021
1
1
—None
$15
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.